| Home | ||
| About NCCTG | ||
| About Clinical Trials | ||
NCCTG Trial Listings
| ||
| Treating Locations | ||
| NCCTG News | ||
| Links | ||
| Patient Advocacy | ||
| Institutional Members Only |
The following NCCTG cancer treatment clinical trials are currently active. You may click on the trial number to link to a detailed description on PDQ, the National Cancer Institute's Web site for clinical trials.
| E2104 | Phase II Feasibility Trial Incorporating Bevacizumab Into Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Patients with Lymph Node Positive Breast Cancer |
For more information, please discuss these trials with your physician, contact the NCCTG Operations Office or contact an NCCTG treating location near you.
Return to list of Cancer Treatment Trials
© Copyright 2006, NCCTG